By


Annovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease
Manuscript Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Study adds further validation that Annovis’ lead compound is the only drug to improve axonal transport, the information highway of the nerve cell   

See more here

By


IVIEW Collaboration With Dr. Amin Javer at St. Paul’s Hospital and Sinus Centre, Canada to Study Povidone Iodine Formulations Including IVIEW-1503, a Long-Lasting Povidone Iodine Nasal Spray for the Treatment of COVID-19

See more here

By


Venatorx Pharmaceuticals Names William Sargent Senior Vice President, Commercial Strategy

See more here

By


Immunome Announces Creation of COVID-19 Advisory Board
Advisory Board to help guide development and clinical testing of biosynthetic convalescent plasma as a potential COVID-19 treatment and prevention of disease  

See more here

By


Melior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic in COVID-19 Phase 2 Clinical Trial

  • Melior’s therapeutic candidate, tolimidone, is:  
    • Expected to mitigate the probability and severity of COVID-19 subjects developing severe lung complications 
    • A repositioned drug that has been demonstrated to be safe and well-tolerated in previous clinical studies 

See more here

By


Everest Medicines Announces Top-line Results from Phase 1 Clinical Trial of Taniborbactam in Combination with Cefepime in China

See more here

By


Wellsheet Deployed by RWJBarnabas Health Improves Clinical Workflow and Improves Patient Care
Wellsheet Reduces Doctors’ Time in the EHR Chart by 40%   

See more here

By


Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial

See more here